DAVID WOODMANSEE, RPH
Pharmacy at Vandever Ave, San Diego, CA
License number
California 28064
Category
Pharmacy
Type
Pharmacotherapy
Address
Address
4405 Vandever Ave, San Diego, CA 92120
Phone
(619) 516-6205
(619) 516-7599 (Fax)
(619) 516-7599 (Fax)
Personal information
See more information about DAVID WOODMANSEE at radaris.comName
Address
Phone
2966 Kobe Dr, San Diego, CA 92123
14462 Fox St, Mission Hills, CA 91345
14462 Fox St, Mission Hills, CA 91345
794 Cypress Walk, Goleta, CA 93117
760 Oak Walk, Goleta, CA 93117
Professional information
David Woodmansee, San Diego CA - RPH
Specialties:
Pharmacotherapy
Address:
4405 Vandever Ave, San Diego 92120
(619) 516-6205 (Phone), (619) 516-7599 (Fax)
(619) 516-6205 (Phone), (619) 516-7599 (Fax)
Languages:
English
Inhibitors Of Cathepsin S
US Patent:
2005011, May 26, 2005
Filed:
Aug 18, 2004
Appl. No.:
10/922515
Inventors:
Hong Liu - San Diego CA, US
Arnab Chatterjee - Encinitas CA, US
David Tully - San Diego CA, US
Phillip Alper - Poway CA, US
Badry Bursulaya - San Diego CA, US
Jianhua Guo - San Diego CA, US
David Woodmansee - San Diego CA, US
Daniel Mutnick - San Diego CA, US
Donald Karanewsky - Escondido CA, US
Yun He - San Diego CA, US
Arnab Chatterjee - Encinitas CA, US
David Tully - San Diego CA, US
Phillip Alper - Poway CA, US
Badry Bursulaya - San Diego CA, US
Jianhua Guo - San Diego CA, US
David Woodmansee - San Diego CA, US
Daniel Mutnick - San Diego CA, US
Donald Karanewsky - Escondido CA, US
Yun He - San Diego CA, US
Assignee:
IRM LLC - Hamilton
International Classification:
A61K031/54, A61K031/537, A61K031/495, A61K031/445, A61K031/401, A61K031/397
US Classification:
514210170, 514227500, 514237500, 514255010, 514317000, 514419000, 514423000, 544059000, 544162000, 544386000, 546226000, 548492000, 548537000, 548953000
Abstract:
The present invention provides compounds, compositions and methods for the selective inhibition of cathepsin S. In a preferred aspect, cathepsin S is selectively inhibited in the presence of at least one other cathepsin isozyme. The present invention also provides methods for treating a disease state in a subject by selectively inhibiting cathepsin S.
Compounds And Compositions As Cathepsin S Inhibitors
US Patent:
8268996, Sep 18, 2012
Filed:
Jun 16, 2011
Appl. No.:
13/161555
Inventors:
Hong Liu - San Diego CA, US
David C. Tully - San Diego CA, US
Arnab Chatterjee - Encinitas CA, US
Phillip B. Alper - Poway CA, US
David H. Woodmansee - San Diego CA, US
Daniel Mutnick - San Diego CA, US
David C. Tully - San Diego CA, US
Arnab Chatterjee - Encinitas CA, US
Phillip B. Alper - Poway CA, US
David H. Woodmansee - San Diego CA, US
Daniel Mutnick - San Diego CA, US
Assignee:
IRM LLC - Hamilton
International Classification:
C07D 413/12, C07D 295/185, A61K 31/5377, A61K 31/5375
US Classification:
544130, 544163, 5142372, 5142385
Abstract:
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cathepsin S.
Compounds And Compositions As Inhibitors Of Cannabinoid Receptor 1 Activity
US Patent:
8158634, Apr 17, 2012
Filed:
Oct 26, 2005
Appl. No.:
11/718016
Inventors:
Hong Liu - San Diego CA, US
Xiaohui He - San Diego CA, US
Ha-Soon Choi - San Diego CA, US
Kunyong Yang - San Diego CA, US
David Woodmansee - San Diego CA, US
Zhicheng Wang - San Diego CA, US
David Archer Ellis - San Diego CA, US
Baogen Wu - San Diego CA, US
Yun He - San Diego CA, US
Truc Ngoc Nguyen - Vista CA, US
Xiaohui He - San Diego CA, US
Ha-Soon Choi - San Diego CA, US
Kunyong Yang - San Diego CA, US
David Woodmansee - San Diego CA, US
Zhicheng Wang - San Diego CA, US
David Archer Ellis - San Diego CA, US
Baogen Wu - San Diego CA, US
Yun He - San Diego CA, US
Truc Ngoc Nguyen - Vista CA, US
Assignee:
IRM LLC - Hamilton
International Classification:
C07D 487/04, A61K 31/519, A61P 3/04, C07D 471/04, C07D 473/30, A61K 31/5025, A61K 31/5365
US Classification:
5142621, 544262, 544254, 544264, 544255, 544350, 546118, 514249, 5142601, 5142611, 5142631, 514303
Abstract:
The invention provides compounds having Formula Ia,.
Compounds And Compositions As Cathepsin S Inhibitors
US Patent:
7985749, Jul 26, 2011
Filed:
Apr 29, 2005
Appl. No.:
11/568459
Inventors:
Hong Liu - San Diego CA, US
David C. Tully - San Diego CA, US
Arnab Chatterjee - Encinitas CA, US
Phillip B. Alper - Poway CA, US
David H. Woodmansee - San Diego CA, US
Daniel Mutnick - San Diego CA, US
David C. Tully - San Diego CA, US
Arnab Chatterjee - Encinitas CA, US
Phillip B. Alper - Poway CA, US
David H. Woodmansee - San Diego CA, US
Daniel Mutnick - San Diego CA, US
Assignee:
Novartis AG - Basel
International Classification:
A61K 31/5355, C07D 413/12
US Classification:
5142338, 544127, 544135, 544137, 544138, 546198, 548217, 5142368, 514321, 514375
Abstract:
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cathepsin S.
Inhibitors Of Cathepsin S
US Patent:
7384970, Jun 10, 2008
Filed:
Mar 23, 2004
Appl. No.:
10/807613
Inventors:
Hong Liu - San Diego CA, US
Phil Alper - Poway CA, US
Arnab Chatterjee - Encinitas CA, US
David Tully - San Diego CA, US
Badry Bursulaya - San Diego CA, US
David Woodmansee - San Diego CA, US
Robert Epple - San Diego CA, US
Jennifer Leslie Harris - San Diego CA, US
Jun Li - San Diego CA, US
Phil Alper - Poway CA, US
Arnab Chatterjee - Encinitas CA, US
David Tully - San Diego CA, US
Badry Bursulaya - San Diego CA, US
David Woodmansee - San Diego CA, US
Robert Epple - San Diego CA, US
Jennifer Leslie Harris - San Diego CA, US
Jun Li - San Diego CA, US
Assignee:
IRM LLC - Hamilton
International Classification:
A61K 31/4045, C07D 209/08
US Classification:
514415, 548491
Abstract:
The present invention provides compounds, compositions and methods for the selective inhibition of cathepsin S. In a preferred aspect, cathepsin S is selectively inhibited in the presence of at least one other cathepsin isozyme. The present invention also provides methods for treating a disease state in a subject by selectively inhibiting cathepsin S.